Hims & Hers Health, Inc.
HIMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,221 | $1,863 | $1,311 | $1,223 |
| - Cash | $221 | $97 | $47 | $72 |
| + Debt | $11 | $10 | $5 | $5 |
| Enterprise Value | $5,012 | $1,776 | $1,269 | $1,157 |
| Revenue | $1,477 | $872 | $527 | $272 |
| % Growth | 69.3% | 65.5% | 93.8% | – |
| Gross Profit | $1,173 | $715 | $409 | $204 |
| % Margin | 79.5% | 82% | 77.6% | 75.2% |
| EBITDA | $79 | -$20 | -$61 | -$111 |
| % Margin | 5.3% | -2.3% | -11.6% | -40.8% |
| Net Income | $126 | -$24 | -$66 | -$108 |
| % Margin | 8.5% | -2.7% | -12.5% | -39.6% |
| EPS Diluted | 0.53 | -0.11 | -0.32 | -0.58 |
| % Growth | 581.8% | 65.6% | 44.8% | – |
| Operating Cash Flow | $251 | $73 | -$27 | -$34 |
| Capital Expenditures | -$53 | -$26 | -$7 | -$5 |
| Free Cash Flow | $198 | $47 | -$34 | -$39 |